Federal public-health programs that track and respond to tick-borne and other vector-borne diseases, such as Lyme disease, would get an extended operating window under this bill. It renews congressional authorization for the National Strategy and Regional Centers of Excellence in Vector-Borne Disease, run through the CDC, stretching funding authority from the 2021–2025 window to 2026–2030. It also broadens the group of experts consulted on the strategy beyond a single tick-borne disease working group, and extends by the same five years a separate CDC program that helps state and local health departments respond to vector-borne disease outbreaks. Health departments, researchers, and Americans living in tick-affected regions would be affected by the continued funding through 2030.
Average Household Impact
- Vector-borne disease program funding — CDC tick-disease programs reauthorized through fiscal year 2030
Congressional Summary
This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.
Legislative Subjects
Details
- Congress
- 119th
- Chamber
- House
- Status
- summarized
- Action
- Reported to House
- Action Date
- 2026-07-02
- Date Added
- 2026-07-17
- Source
- Congress.gov →
Like reading a bill in plain English?
We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.